← FDA DRUG APPROVALS

FDA ANDA · ANDA087677

HY-PHEN

Sponsor: ASCHER

APPLICATION
ANDA087677
TYPE
ANDA
ORIGINAL APPROVAL
1982-05-03
LATEST ACTION
1995-03-09
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

HY-PHENDiscontinued
ACETAMINOPHEN 500MG, HYDROCODONE BITARTRATE 5MG · TABLET · ORAL

Approval history

1995-03-09Labeling · Supplement 10AP
1993-10-14Labeling · Supplement 9AP
1992-10-27Manufacturing (CMC) · Supplement 8AP
1986-12-29Manufacturing (CMC) · Supplement 5AP
1983-08-01Manufacturing (CMC) · Supplement 1AP
1982-05-03OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →